Maochen Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Lactoferrin blocks orthopoxvirus entry via heparan sulphate and regulates host antiviral pathways.
Journal: Emerging microbes & infections
Published: March 06, 2026
A comprehensive review of research advances in the study of lactoferrin to treat viral infections.
Journal: Life sciences
Published: July 12, 2024
Antibody-dependent enhancement of coronaviruses.
Journal: International journal of biological sciences
Published: March 08, 2024
Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery.
Journal: Nature communications
Published: April 09, 2023
Acinetobacter Baumannii Phages: Past, Present and Future.
Journal: Viruses
Published: January 18, 2023
Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1 by targeting the RdRp complex and alleviates viral infection in the hamster model.
Journal: Journal of medical virology
Published: August 17, 2022
The monkeypox outbreak in 2022: adaptive evolution associated with APOBEC3 may account for.
Journal: Signal transduction and targeted therapy
Published: July 28, 2022
Cepharanthine: A Promising Old Drug against SARS-CoV-2.
Journal: Advanced biology
Published: May 26, 2022
COVID-19 vaccine development: milestones, lessons and prospects.
Journal: Signal transduction and targeted therapy
Published: February 06, 2022
Molnupiravir and Its Antiviral Activity Against COVID-19.
Journal: Frontiers in immunology
Published: January 15, 2022
SARS-CoV-2 variant Omicron: currently the most complete "escapee" from neutralization by antibodies and vaccines.
Journal: Signal transduction and targeted therapy
Published: December 29, 2021
Efficient disinfection of SARS-CoV-2-like coronavirus, pseudotyped SARS-CoV-2 and other coronaviruses using cold plasma induces spike protein damage.
Journal: Journal of hazardous materials
Published: December 11, 2021
Last Updated: 09/26/2026